|
Employee Benefit Plans (Stock Options And Restricted Stock Units Under All Equity Plans (Except 2005 Director's Plan)) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified |
12 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Oct. 31, 2011
years
|
Oct. 31, 2010
years
|
Oct. 31, 2009
years
|
Oct. 31, 2008
years
|
||||||||||
| Available for Grant, Beginning Balance | 2,606,000 | [1] | 6,703,000 | [1] | 4,347,000 | [1] | |||||||
| Available for Grant, Options Granted | (2,228,000) | [1] | (1,995,000) | [1] | (1,395,000) | [1] | |||||||
| Available for Grant, Options Canceled/forfeited/expired | 550,000 | [1] | 372,000 | [1] | 2,113,000 | [1] | |||||||
| Available for Grant, Restricted stock units granted | (2,182,000) | [1],[2] | (2,677,000) | [1],[2] | (2,476,000) | [1],[2] | |||||||
| Available for Grant, Restricted stock units forfeited | 165,000 | [1],[2] | 203,000 | [1],[2] | 114,000 | [1],[2] | |||||||
| Available for Grant, Additional shares reserved | 7,000,000 | [1] | 4,000,000 | [1] | |||||||||
| Available for Grant, Ending Balance | 5,911,000 | [1] | 2,606,000 | [1] | 6,703,000 | [1] | |||||||
| Options Outstanding, Options Granted | 2,270,000 | 1,995,000 | 1,395,000 | ||||||||||
| Options Outstanding, Options Assumed | 456,000 | [3] | |||||||||||
| Options Outstanding, Options Exercised | (6,800,000) | (6,465,000) | (2,112,000) | ||||||||||
| Options Outstanding, Options Canceled/forfeited/expired | (694,000) | (620,000) | (2,242,000) | ||||||||||
| Options Outstanding, Vested and expected to vest | 15,762,000 | ||||||||||||
| Options Outstanding, Exercisable | 12,051,000 | ||||||||||||
| Weighted- Average Exercise Price per Share, Beginning Balance | $ 21.83 | $ 21.22 | $ 21.52 | ||||||||||
| Weighted- Average Exercise Price per Share, Options Granted | $ 26.07 | $ 21.30 | $ 18.16 | ||||||||||
| Weighted- Average Exercise Price per Share, Options Assumed | $ 18.10 | [3] | |||||||||||
| Weighted- Average Exercise Price per Share, Options Exercised | $ 20.53 | $ 18.16 | $ 18.07 | ||||||||||
| Weighted- Average Exercise Price per Share, Options Canceled/forfeited/expired | $ 27.24 | $ 23.19 | $ 26.06 | ||||||||||
| Weighted- Average Exercise Price per Share, Ending Balance | $ 22.76 | $ 21.83 | $ 21.22 | ||||||||||
| Weighted- Average Exercise Price per Share, Vested and expected to vest | $ 22.73 | ||||||||||||
| Weighted- Average Exercise Price per Share, Exercisable | $ 22.59 | ||||||||||||
| Weighted-Average Remaining Contractual Life (In Years) | 2.97 | 2.80 | 2.89 | 3.43 | |||||||||
| Weighted-Average Remaining Contractual Life (In Years), Vested and expected to vest | 2.93 | ||||||||||||
| Weighted-Average Remaining Contractual Life (In Years), Exercisable | 2.06 | ||||||||||||
| Aggregate Intrinsic Value | $ 74,068 | $ 90,013 | $ 58,267 | $ 15,403 | |||||||||
| Aggregate Intrinsic Value, Vested and expected to vest | 73,554 | ||||||||||||
| Aggregate Intrinsic Value, Exercisable | $ 58,779 | ||||||||||||
| Company's End of period closing stock price | $ 27.19 | ||||||||||||
|
All Stock Plans [Member]
|
|||||||||||||
| Options Outstanding, Beginning Balance | 28,777,000 | ||||||||||||
| Options Outstanding, Ending Balance | 15,960,000 | 21,184,000 | 25,818,000 | 28,777,000 | |||||||||
|
|||||||||||||
| X | ||||||||||
|
- Definition
Share-based compensation arrangement by share-based payment award, number of shares available for grant, additional shares reserved No definition available.
|
| X | ||||||||||
|
- Definition
Share-based compensation arrangement by share-based payment award, number of shares available for grant, options canceled/forfeited/expired No definition available.
|
| X | ||||||||||
|
- Definition
Share-based compensation arrangement by share-based payment award, number of shares available for grant, options granted No definition available.
|
| X | ||||||||||
|
- Definition
Share-based compensation arrangement by share-based payment award, number of shares available for grant, restricted stock units forfeited No definition available.
|
| X | ||||||||||
|
- Definition
Share-based compensation arrangement by share-based payment award, number of shares available for grant, restricted stock units granted No definition available.
|
| X | ||||||||||
|
- Definition
Share-based compensation arrangement by share-based payment award, options, options assumed in period No definition available.
|
| X | ||||||||||
|
- Definition
Share-based compensation arrangement by share-based payment award, options, options assumed in period, weighted average exercise price No definition available.
|
| X | ||||||||||
|
- Definition
The dollar amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The total dollar difference between fair values of the underlying shares reserved for issuance and exercise prices of vested portions of options outstanding and currently exercisable under the option plan as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The weighted average period between the balance sheet date and expiration for all vested portions of options outstanding and currently exercisable (or convertible) under the plan, which may be expressed in a decimal value for number of years. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The weighted average price at which option holders acquired shares when converting their stock options into shares under the plan during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated during the reporting period due to noncompliance with plan terms during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The weighted average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on stock options awarded under the plan during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The total dollar difference between fair values of the underlying shares reserved for issuance and exercise prices pertaining to options outstanding under the plan as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The weighted average price as of the beginning of the year at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The weighted average period between the balance sheet date and expiration for all awards outstanding under the plan, which may be expressed in a decimal value for number of years. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
As of the balance sheet date, the total dollar difference between fair values of the underlying shares reserved for issuance and exercise prices of fully vested and expected to vest options outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
As of the balance sheet date, the weighted-average exercise price for outstanding stock options that are fully vested or expected to vest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The weighted-average period between the balance sheet date and expiration date for fully vested and expected to vest options outstanding, which may be expressed in a decimal value for number of years. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|